SupplySide Stage – Thin people, fat opportunity: How Ozempic could shape the supplement industry

According to Axios, Morgan Stanley analysts projected that over the next 10 years, 7% of the U.S. population could be taking weight loss drugs such as Ozempic. What does that mean for the supplement industry if 24 million people are eating less? It means opportunity. Stop by the SupplySide Stage for what’s sure to be an enlightening presentation on how Ozempic is impacting the market — and related areas that nutritional supplement brands and ingredient suppliers can leverage.